Analysis of Codon Usage Bias Between Entomopathogenic Fungus <i>Ophiocordyceps sinensis</i> and Its Host, <i>Thitarodes xiaojinensis</i>. [PDF]
Yan J +7 more
europepmc +1 more source
The Clinical Pharmacogenetics Implementation Consortium (CPIC) TPMT/NUDT15 Pharmacogene Curation Expert Panel (PCEP) conducted a comprehensive review of clinical, laboratory, and computational evidence to determine the clinical function assignments for TPMT and NUDT15 star alleles.
Bailey M. Tibben +10 more
wiley +1 more source
Comparative analysis of codon usage bias and phylogenetic relationships in chloroplast genomes across 49 Dendrobium species. [PDF]
Wu C +9 more
europepmc +1 more source
We generated and compared the complete chloroplast genomes of Reyesia chilensis and Salpiglossis sinuata, two representative species of the tribe Salpiglossideae (subfamily Cestroideae) within Solanaceae. Comparative plastome analyses revealed highly conserved genome organization, codon usage, and repeat composition, while phylogenetic analyses ...
Jie Huang +3 more
wiley +1 more source
Mitochondrial Genome of <i>Abramis brama orientalis</i> Reveals Dominant Role of Natural Selection over Mutation Pressure in Shaping Codon Usage Bias in Leuciscinae Fishes. [PDF]
Hao CL +8 more
europepmc +1 more source
Codon Usage Bias in Human RNA Viruses and Its Impact on Viral Translation, Fitness, and Evolution. [PDF]
Ventoso I.
europepmc +1 more source
Abstract Non‐standard amino acids (ncAAs) together with synthetic additions (like caps and linkers) are of wide interest for protein design and pharmaceutical optimization, as they can improve physicochemical properties and possibly reshape protein structure. Their inclusion in experimental structures has not been explored systematically.
Alex Waldherr +2 more
wiley +1 more source
Plastome evolution in annual Brachypodium species reveals widespread heteroplasmy and chloroplast capture, lineage-specific codon usage bias, and low positive selection. [PDF]
Campos M +3 more
europepmc +1 more source
Covalent drug discovery: Progress against key targets, emerging strategies and lessons learnt
Abstract Covalent drug discovery is currently experiencing a boom in industrial and academic interest. To date, at least 75 covalent drugs have received regulatory approval, targeting both traditional target classes and more challenging proteins for which other approaches failed. In many cases, unique aspects of covalent targeting are essential for the
Charles P. Brown +2 more
wiley +1 more source
Complete Mitochondrial Genome Sequencing of <i>Brachypelma albiceps</i> and Comparative Codon Usage Bias Analysis Across Seven Mygalomorphae Species. [PDF]
Zhan Q +7 more
europepmc +1 more source

